J. David Becherer

7.3k citations

51 papers · 4.4k indexed · h-index 35

Impact in

Immunology and Allergy top 0.5%
- Cell Adhesion Molecules Research
Cancer Research top 2%
- Protease and Inhibitor Mechanisms

Papers in

Immunology and Allergy 12
- Cell Adhesion Molecules Research 12
Physiology 6
- Calcium signaling and nucleotide metabolism 5

Co-authors: Carl Blobel Johannes Schlöndorff John D. Lambris Paul Tempst Hediye Erdjument‐Bromage Marcia L. Moss Lawrence Lum Gisela Weskamp
Journals: Journal of Biological Chemistry (8 papers)Journal of Medicinal Chemistry (3 papers)Biochemistry (3 papers)Combinatorial Chemistry & High Throughput Screening (2 papers)The Journal of Immunology (2 papers)
Partner nations: United States Switzerland Germany

In The Last Decade

J. David Becherer

51 papers receiving 4.3k citations

Peers

Countries citing papers authored by J. David Becherer

Since Specialization

Citations

This map shows the geographic impact of J. David Becherer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. David Becherer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. David Becherer more than expected).

Fields of papers citing papers by J. David Becherer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. David Becherer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. David Becherer. The network helps show where J. David Becherer may publish in the future.

Co-authorship network

The 25 scholars most cited alongside J. David Becherer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with J. David Becherer Line = papers co-authored together J. David Becherer links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Abstract P233: Inhibition Of Aldosterone Synthesis In Non-human Primates By PB6440, The Novel Highly Selective And Potent CYP11B2 Inhibitor Hypertension ·Bertram Pitt, Deepak L. Bhatt, Christopher Henshall, J. David Becherer, William J. Hoekstra, MạnhTuấn Vũ, Steven M. Sparks, John S. Lee	2020	1
2	Complementary NAD+ replacement strategies fail to functionally protect dystrophin-deficient muscle Skeletal Muscle ·David W. Frederick, 春木繁一, Zhang Dong-hao, Johanna Vappiani, Andrea Nuzzo, John C. Ulrich, J. David Becherer, Frank Preugschat, Eugene L. Stewart, Daniel C. Sévin, Henning F. Kramer	2020	14
3	Genetic Ablation of CD38 Protects against Western Diet-Induced Exercise Intolerance and Metabolic Inflexibility PLoS ONE ·Shian-Huey Chiang, W. Wallace Harrington, Guizhen Luo, Nikoletta Kontoulis, John C. Ulrich, Jing Chen, Deepak K. Rajpal, Ying Qian, Tiffany Carpenter, D.S. Hadmoko, Robert S. Geske, Stephen A. Stimpson, Henning F. Kramer, Curt D. Haffner, J. David Becherer, Frank Preugschat, Andrew N. Billin	2015	31
4	A Disintegrin and Metalloproteinase-10 (ADAM-10) Mediates DN30 Antibody-induced Shedding of the Met Surface Receptor Journal of Biological Chemistry ·Florian Schelter, Trevor NACE, Marcia L. Moss, J. David Becherer, Paolo M. Comoglio, Carla Boccaccio, Achim Krüger	2010	62
5	Pyrrolidinyl pyridone and pyrazinone analogues as potent inhibitors of prolyl oligopeptidase (POP) Bioorganic & Medicinal Chemistry Letters ·Curt D. Haffner, Darin L. Powers, Aaron B. Miller, Robert A. Reid, Kevin P. Madauss, Annie M. Hassell, Mary H. Hanlon, David Porter, J. David Becherer, Susan Sangilu Imbahale	2008	47
6	Predicting QT prolongation in humans during early drug development using hERG inhibition and an anaesthetized guinea‐pig model British Journal of Pharmacology ·Xiaozhou Yao, D. L. Anderson, Sean Ross, Daniel G. Lang, Jubao Lyu, D. C. Cooper, Pat Wheelan, Maggie S. McIntyre, Maria Bergquist, N Roncoglia, J. David Becherer, Tria Dwi Astuti	2008	56
7	ADAM10 is a principal 'sheddase' of the low-affinity immunoglobulin E receptor CD23 Nature Immunology ·Gisela Weskamp, Jill Ford, Jamie Sturgill, Steve L. Martin, Andrew Docherty, Steven Swendeman, Neil Broadway, Dieter Hartmann, Paul Säftig, Shelby P. Umland, Atsuko Sehara‐Fujisawa, Roy A. Black, Andreas Ludwig, J. David Becherer, Daniel H. Conrad, Carl Blobel	2006	162
8	Propranolol inhibits the human ether-a-go-go-related gene potassium channels European Journal of Pharmacology ·Xiaozhou Yao, Maggie S. McIntyre, Daniel G. Lang, Ivy Song, J. David Becherer, Mir A. Hashim	2005	13
9	Expression of Tissue Inhibitor of Metalloproteinases by Recombinant Baculovirus-Infected Insect Cells Cultured in an Airlift Fermentor Humana Press eBooks ·Laurie K. Overton, Indravadan R. Patel, J. David Becherer, 厚生省大臣官房障害保健福祉部企画課, Thomas A. Kost	2003	2
10	Biochemical properties and functions of membrane-anchored metalloprotease-disintegrin proteins (ADAMs) Current topics in developmental biology ·J. David Becherer, Carl Blobel	2003	75
11	The C‐terminal domains of TACE weaken the inhibitory action of N‐TIMP‐3 FEBS Letters ·Meng‐Huee Lee, Vandana Verma, K. Maskos, J. David Becherer, Vera Knäuper, Elm Respublikası, Augustin Amour, Gillian Murphy	2002	29
12	Full-Length and N-TIMP-3 Display Equal Inhibitory Activities toward TNF-α Convertase Biochemical and Biophysical Research Communications ·Meng‐Huee Lee, Vera Knäuper, J. David Becherer, Gillian Murphy	2001	53
13	Specific Sequence Elements Are Required for the Expression of Functional Tumor Necrosis Factor-α-converting Enzyme (TACE) Journal of Biological Chemistry ·Marcos E. Milla, M. Anthony Leesnitzer, Marcia L. Moss, William C. Clay, H. Luke Carter, Ann B. Miller, Jui‐Lan Su, Millard H. Lambert, Derril H. Willard, Douglas M. Sheeley, Thomas A. Kost, William Burkhart, Mary B. Moyer, Kevin Blackburn, Zhang Mao-liang, Justin Mitchell, Christine R. Hoffman, J. David Becherer	1999	134
14	Metalloprotease-Disintegrin MDC9: Intracellular Maturation and Catalytic Activity Journal of Biological Chemistry ·Monireh Roghani, J. David Becherer, Marcia L. Moss, Hua Wen-Ting Zhou Jian-Min, Hediye Erdjument‐Bromage, Joaquı́n Arribas, Kevin Blackburn, Gisela Weskamp, Paul Tempst, Carl Blobel	1999	260
15	Structural features and biochemical properties of TNF-α converting enzyme (TACE) Journal of Neuroimmunology ·Marcia L. Moss, C. Homm, J. David Becherer, D. Mark Bickett, William Burkhart, Creaform, Daniel F. Hassler, I. Savesyuk, Gerard M. McGeehan, Marcos E. Milla, Mary B. Moyer, Warren J. Rocque, Theresa Seaton, Frank J. Schoenen, Janet Warner, Derril H. Willard	1997	86
16	Granzyme A is an interleukin 1 beta-converting enzyme. The Journal of Experimental Medicine ·Martin Irmler, Sylvie Hertig, H. Robson MacDonald, Rémy Sadoul, J. David Becherer, Amanda E. I. Proudfoot, Roberto Solari, Jürg Tschopp	1995	179
17	Regulation of tumour necrosis factor-α processing by a metalloproteinase inhibitor Nature ·Gerard M. McGeehan, J. David Becherer, Robert C. Bast, Cinda M. Boyer, Brian Champion, Kevin Connolly, James G. Conway, Paul J. Furdon, Stephen E. Karp, Dipl.-Ing. Ralf Degner, Andrew B. McElroy, James Nichols, José Eduardo de Resende, Frank J. Schoenen, Les Sekut, Anne T. Truesdale, Margrith W. Verghese, Janet Warner, J P Ways	1994	485
18	Evidence for multiple sites of interaction in C3 for complement receptor type 2 (C3d/EBV receptor, CD21) European Journal of Immunology ·Inmaculada Esparza, J. David Becherer, Jochem Alsenz, Antonio de la Hera, Jae Hyuk Choi, Constantine D. Tsoukas, John D. Lambris	1991	33
19	Structural and Functional Analysis of C3 Using Monoclonal Antibodies Current topics in microbiology and immunology ·Jochem Alsenz, J. David Becherer, Bo Nilsson, John D. Lambris	1990	29
20	Monoclonal anti c3 antibodies specific for either bound or fluid phase c3 mapping of their antigenic sites in c3 by the use of an expression minilibrary The FASEB Journal ·Dario Grossberger, Patricia Riegert, J. David Becherer, Bo Nilsson, Kristina Nilsson Ekdahl, Ulf Nilsson, John D. Lambris	1988	1

About J. David Becherer

J. David Becherer is a scholar working on Immunology and Allergy, Physiology, Hematology, Immunology and Oncology, having authored 51 papers that have together received 4.4k indexed citations. Recurring topics across this work include Cell Adhesion Molecules Research (12 papers), Monoclonal and Polyclonal Antibodies Research (11 papers), Complement system in diseases (9 papers), Protease and Inhibitor Mechanisms (8 papers), Peptidase Inhibition and Analysis (7 papers), Blood groups and transfusion (7 papers), HER2/EGFR in Cancer Research (5 papers) and Calcium signaling and nucleotide metabolism (5 papers). The work is most often cited by research in Immunology and Allergy (834 citations), Cancer Research (847 citations), Immunology (1.1k citations), Oncology (1.4k citations) and Hematology (481 citations). J. David Becherer has collaborated with scholars based in United States, Switzerland and Germany. Frequent co-authors include Carl Blobel, Johannes Schlöndorff, John D. Lambris, Paul Tempst, Hediye Erdjument‐Bromage, Marcia L. Moss, Lawrence Lum, Gisela Weskamp, Millard H. Lambert and Jochem Alsenz. Their work appears in journals such as Journal of Biological Chemistry, Journal of Medicinal Chemistry, Biochemistry, Combinatorial Chemistry & High Throughput Screening and The Journal of Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact